Should We Use Nomograms to Predict Outcome?

European Urology, Supplements

Volumn 7, Issue 5, 2008, Pages 396-399

  Chun, Felix K H ^a,b   Briganti, Alberto ^b,c   Karakiewicz, Pierre I ^b   Graefen, Markus ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Clinical decision making; Individual risk stratification; Nomogram; Prostate cancer

Indexed keywords

ACCURACY; CLINICAL DECISION MAKING; HUMAN; NOMOGRAM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; RELIABILITY; REVIEW; RISK ASSESSMENT;

EID: 44549088270     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2008.01.011     Document Type: Review

References (26)

1. Chun F.K.-H., Karakiewicz P.I., Briganti A., et al. Prostate cancer nomograms: an update. Eur Urol 50 (2006) 914-926 discussion 926
2. Kattan M.W. Nomograms. Introduction. Semin Urol Oncol 20 (2002) 79-81
3. Chun F.K., Graefen M., Zacharias M., et al. Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer. World J Urol 24 (2006) 273-280
4. Ross P.L., Scardino P.T., and Kattan M.W. A catalog of prostate cancer nomograms. J Urol 165 (2001) 1562-1568
5. Guillonneau B. Ceteris paribus and nomograms in medicine. Eur Urol 52 (2007) 1287-1289
6. Ross R.W., and Kantoff P.W. Predicting outcomes in prostate cancer: how many more nomograms do we need?. J Clin Oncol 25 (2007) 3563-3564
7. Ross P.L., Gerigk C., Gonen M., et al. Comparisons of nomograms and urologists' predictions in prostate cancer. Semin Urol Oncol 20 (2002) 82-88
8. Specht M.C., Kattan M.W., Gonen M., Fey J., and Van Zee K.J. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 12 (2005) 654-659
9. Walz J., Gallina A., Perrotte P., et al. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int 100 (2007) 1254-1258
10. Briganti A, Gallina A, Suardi N, et al. A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer. BJU Int. In press.
11. Chun F.K.-H., Graefen M., Briganti A., et al. Initial biopsy outcome prediction-head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. Eur Urol 51 (2007) 1236-1243 (discussion 1241-3)
12. Chun F.K., Karakiewicz P.I., Briganti A., et al. A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer. BJU Int 99 (2007) 794-800
13. Kattan M.W. Comparison of Cox regression with other methods for determining prediction models and nomograms. J Urol 170 (2003) S6-S9 discussion S10
14. Kattan M.W. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol 13 (2003) 111-116
15. Kattan M.W., and Vickers A.J. Incorporating predictions of individual patient risk in clinical trials. Urol Oncol 22 (2004) 348-352
16. Shariat S.F., Canto E.I., Kattan M.W., and Slawin K.M. Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer. Rev Urol 6 (2004) 58-72
17. Chun F.K., Karakiewicz P.I., Huland H., and Graefen M. Role of nomograms for prostate cancer in 2007. World J Urol 25 (2007) 131-142
18. Stephan C., Kramer J., Meyer H.A., et al. Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies. BJU Int 99 (2007) 1427-1431
19. Stephan C., Xu C., Cammann H., et al. Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men. World J Urol 25 (2007) 95-103
20. Stephan C., Xu C., Finne P., et al. Comparison of two different artificial neural networks for prostate biopsy indication in two different patient populations. Urology 70 (2007) 596-601
21. Stephenson A.J., Scardino P.T., Eastham J.A., et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23 (2005) 7005-7012
22. Stephenson A.J., Scardino P.T., Eastham J.A., et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 98 (2006) 715-717
23. Steuber T., Graefen M., Haese A., et al. Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy. J Urol 175 (2006) 939-944 discussion 944
24. Suzuki H., Komiya A., Kamiya N., et al. Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients. Urology 67 (2006) 131-136
25. Yanke B.V., Carver B.S., Bianco Jr. F.J., et al. African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram. BJU Int 98 (2006) 783-787
26. Vickers A.J., Kattan M.W., and Daniel S. Method for evaluating prediction models that apply the results of randomized trials to individual patients. Trials 8 (2007) 14